CHILDHOOD CANCER REPOSITORY

Powered by

Alex's Lemonade Stand Foundation

Patient Derived Xenografts (PDXs)

PDXs, ending in an “x”, are patient direct and have never been in vitro. Xenografts ending in “m” are established from a cell line.

The defination for the abbreviation are given below the table. Please scroll all the way down.

Please click at the top logo to return to home page.

RequestPDX Phase of
Therapy		Sample
Type		 StageMYCN*ALKTERT
mRNA		TMMTp53WESRNA
Seq		Cell Line (CL)Cyclo +
Topo		Injection
Type
COG-N-415x PD-PMBlood4397F1174L+TERTWT✓✓COG-N-415✓SQ
COG-N-421x PD-PMBlood4220WT+TERTWT✓✓COG-N-421✓SQ
COG-N-424x DxTumor 4198WT+TERTWT✓✓-✓SQ
COG-N-440x PD-PMBlood4300WT+TERTWT✓✓COG-N-440✓SQ & TV
COG-N-452x«PD-PMBlood4156F1174L+TERTWT ✓COG-N-452✓SQ
COG-N-453x«PD-PMTumor4 WT+TERTWT ✓COG-N-453 SQ
COG-N-470x PD-PMBlood42F1174L+TERT  ✓COG-N-470✓SQ
COG-N-471x PD-PMBlood4228WT+TERTWT✓✓COG-N-471✓SQ
COG-N-480x DxBM4159WT-ESTWT✓✓COG-N-480h2✓SQ & TV
COG-N-496x DxBM4104WT+TERTWT✓✓COG-N-496✓SQ
COG-N-518x DxBM45  EST  ✓COG-N-518h SQ
COG-N-519x PD-PMBlood4775WT+TERTWT✓✓COG-N-519✓SQ
COG-N-546x DxBM4334     ✓COG-N-546 SQ
COG-N-549x PDTumor42F1174L+TERTWT✓✓COG-N-549✓SQ
COG-N-557x DxTumor4 F1245L+TERTWT✓✓COG-N-557✓SQ
COG-N-560x DxTumor 4 WT+TERTWT✓✓-✓SQ
COG-N-561x PD-PMBlood4 F1245I+TERTWT✓✓COG-N-561✓SQ & TV
COG-N-564x PD-PMBlood4 WT+TERTWT✓✓COG-N-564h SQ
COG-N-573x DxBM4  +TERT  ✓COG-N-573✓SQ & TV
COG-N-579x PDBM4      ✓COG-N-579✓SQ
COG-N-589x DxTumor4 WT - ALTWT✓✓COG-N-589 SQ
COG-N-590x DxTumor4 WT+TERTWT✓✓COG-N-590✓SQ
COG-N-603x«DxTumor4 WT+TERTWT✓✓COG-N-603✓SQ
COG-N-615x PD-PMBlood4  +TERT  ✓COG-N-615 SQ
COG-N-618x«PDBM4 WT+TERTWT✓✓COG-N-618✓SQ
COG-N-619x«PDBM4 WT+TERTWT✓✓COG-N-619 SQ
COG-N-620x PDTumor4 WT-ALTWT✓✓- SQ
COG-N-623x«PDTumor4 WT+TERTWT✓✓COG-N-623 SQ
COG-N-624x PDTumor4 WT+TERTWT✓✓- SQ
COG-N-625x PDTumor4 WT - ALTWT✓✓COG-N-625hnb✓SQ
COG-N-627x DxTumor4      ✓COG-N-627hnb SQ
COG-N-628x DxBM4 WT+TERTWT✓✓COG-N-628✓SQ
COG-N-636x DxTumor4  +TERT  ✓COG-N-636✓SQ
COG-N-649x DxTumor4  -EST ✓✓- SQ
COG-N-653x DxTumor4      ✓COG-N-652h✓SQ
COG-N-660x PD-PMBlood4      ✓COG-N-660hnb SQ
COG-N-669x PD-PMBlood4   ALT  ✓- SQ
COG-N-672x PD-PMBlood4      ✓COG-N-672✓SQ
COG-N-676x PDTumor4      ✓- SQ
COG-N-677x PDBM4      ✓- SQ
COG-N-682x DxBM4      ✓COG-N-682 SQ
COG-N-683x DXBM4      ✓COG-N-683✓SQ
COG-N-685x PD-PMBlood4      ✓COG-N-685 SQ
COG-N-695x DxTumor4      ✓- SQ
COG-N-697x DxTumor4      ✓COG-N-697h SQ
COG-N-699x DxTumor4   ALT  ✓- SQ
COG-N-700x DxTumor4   ALT  ✓COG-N-700 SQ
Felix-PDX PD-PMBlood43F1245C+ R342✓✓Felix S


1 - Phase of therapy for the patient at the time the specimen used to derive the cell line was obtained
Dx (Diagnosis): cell lines derived from samples of patients prior to treatment
PD (Progressive Disease): cell lines derived from samples of patients who relapsed after chemotherapy
PD-BMT: cell lines derived from samples of patients who relapsed after chemotherapy and bone marrow transplantation
PD-PM: cell lines derived from samples of post-mortem patients who relapsed after chemotherapy

BM- Bone Marrow

2 -MYCN oncogene amplification
N: MYCN Non-Amplified
A: MYCN Amplified

3 - TP53 gene function
F: Functional
N: Non-Functional

4 - EWS/FLI1 Status
FLI1: friend leukemia insertion - chromosome 11, t(11;22)
ERG: ets-related gene - chromosome 21, t(21;22)

ALK mutation

WT: Wild Type

TMM:Telomere Maintenance mechanism

✓ = Available/available upon request

SQ- subcutaneous injection

TV- intravenous (tail vein)

EST- ever shorter telomeres, i.e. telomerase and ALT negative

TERT+- telomerase positive

ALT - alternate lengthening of telomeres, C-circle positive

Cyclo + Topo - PDX was assessed for response in mice to cyclophosphamide + topotecan.

WES - Whole Exome Secovencing